KCF-S | RING C1x-C1x-C1y(C1z)-C1y(C2x)-C1y-C1x- |
C1x-C1z(C5a+O7a)-C1z(C1a) | |
Pathway | hsa04080 Neuroactive ligand-receptor interaction |
Drug | D00952 Megestrol acetate (antineoplastic) |
D01299 Chlormadinone acetate (progestin) | |
D01368 Cyproterone acetate (anti-androgen) | |
Protein | hsa:10800 cysteinyl leukotriene receptor 1 |
hsa:1128-hsa:1133 muscarinic acetylcholine receptor M1 - M5 | |
hsa:1134 nicotinic acetylcholine receptor alpha-1 | |
hsa:1268 cannabinoid receptor 1 | |
hsa:134,hsa:135,hsa:140 adenosine A1 receptor A1, A2a, A3 | |
hsa:146,hsa:150,hsa:151 adrenergic receptor alpha-1D,2A,2B | |
hsa:1511 cathepsin G | |
hsa:152 adrenergic receptor alpha-2C | |
hsa:153-hsa:155 adrenergic receptor beta-1,2,3 | |
hsa:1812-hsa:1816 dopamine receptor D1-D5 | |
hsa:185-hsa:186 angiotensin II receptor type 1,2 | |
hsa:1909-hsa:1910 endothelin receptor type A, B | |
hsa:2908 glucocorticoid receptor | |
hsa:3269,hsa:3274 histamine receptor H1,H2 | |
hsa:3356,hsa:3357,hsa:3358 5-hydroxytryptamine receptor 2 | |
hsa:3362 5-hydroxytryptamine receptor 6 | |
hsa:4159-hsa:4161 melanocortin receptor 3,4,5 | |
hsa:4886,hsa:4887 neuropeptide Y receptor type 1/4/6,2 | |
hsa:4985 delta-type opioid receptor | |
hsa:4986 kappa-type opioid receptor | |
hsa:4988 mu-type opioid receptor | |
hsa:552 arginine vasopressin receptor 1A | |
hsa:5724 platelet-activating factor receptor | |
hsa:624 bradykinin receptor B2 | |
hsa:6865,hsa:6869 tachykinin receptor 1,2 | |
hsa:7068 thyroid hormone receptor beta | |
hsa:7253 thyroid stimulating hormone receptor | |
hsa:7433 vasoactive intestinal peptide receptor 1 | |
hsa:886 cholecystokinin A receptor |